At 12 months post-treatment, participants' total medical costs reduced by 50 percent, ER costs by 64 percent, and medication costs by 53 percent.
Highmark Health, Allegheny Health Network, and Palo Alto Health Sciences, manufacturer of Freespira, today announced the results of a pilot program completed through Highmark Health's VITAL Program. ... |